Pimodivir
- Generic Name
- Pimodivir
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H19F2N5O2
- CAS Number
- 1629869-44-8
- Unique Ingredient Identifier
- DFC121MXC3
- Background
Pimodivir is under investigation in clinical trial NCT02658825 (A Study to Evaluate the Effect of JNJ-63623872 on Cardiac Repolarization Interval in Healthy Participants).
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-08-25
- Last Posted Date
- 2020-03-27
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 102
- Registration Number
- NCT02532283
Study to Assess the Absorption, Metabolism and Excretion of 14C-JNJ-63623872 After a Single Dose in Healthy Male Participants
- First Posted Date
- 2015-05-19
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- Janssen Cilag N.V./S.A.
- Target Recruit Count
- 6
- Registration Number
- NCT02448004
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath